Although previous studies have shown that Colorado tick fever virus occurs only transiently in the serum, but persists for prolonged periods in the blood cell fraction of man and experimental animals, the exact nature of this cell-associated viraemia was unknown. Using virus isolation, fluorescent antibody staining, histological and electron-microscopic techniques, we have shown that persistent viraemia is predominantly due to virus contained within erythrocytes. Erythrocyte precursor cells are presumably infected in the bone marrow and are subsequently released into the blood stream, persisting for prolonged periods despite the presence of serum antibody. Virus either continues to replicate slowly or is stabilized and remains viable within the erythrocyte. Colorado tick fever virus may be a useful model virus for further study of the mechanism of blood cell infection, with implications for other arboviruses or viruses believed to be involved in leukaemia or other haematological disorders.
INTRODUCTION
Several studies reported in the literature describe the prolonged viraemia in man and wildlife species infected with Colorado tick fever virus: ~7 days in man (Eklund, Kennedy & Casey, I96I) , 15 to 50 days in experimentally infected monkeys (Gerloff & Larson, ~959) , and similarly prolonged periods in other naturally or experimentally infected animals (Burgdorfer, 1959, I96o; Burgdorfer & Eklund, 1959) .
The association of this virus with blood cells was first noted in our laboratory in I96I. The blood cells and plasma from heparinized blood of a chipmunk, Eutamias amoenus (M-919) , trapped in Modoc County, California, were tested separately, and both were positive for virus at the time of capture, but at 17 and 38 days after capture only the cell fraction yielded virus. At 60 days both plasma and blood cells were negative for virus. A non-neuroadapted stock strain of the virus was prepared by subcutaneous passage of blood cell suspension in adult mice. Virus persisted in the blood cells of infected mice to 38 days after inoculation, but was present in the serum for only a few days. Repeated washing of the blood cells and removal of the buffy coat failed to reduce the virus titre in the remaining red blood cell fraction (H. N. Johnson, unpublished studies).
Subsequent studies in man and experimentally infected animals confirmed that the virus was associated largely with the erythrocyte fraction rather than the leucocyte fraction of the blood and showed the value of fluorescent antibody staining to identify virus antigen in blood cells (Emmons, I965, 1966 (Emmons, I965, , 1967 Emmons & Lennette, I966) . Persistent viraemia was demonstrated by virus isolation from washed blood cells and by fluorescent antibody staining of blood smears from human cases. It was hypothesized that the virus infected developing cells in the bone marrow, and that infection persisted through the various stages of maturation and in mature blood cells released into the circulation (Emmons, 1965 (Emmons, , 1967 . We now report evidence from infectivity and electron microscopic studies that the persistent viraemia in Colorado tick fever is due predominantly to virus contained within erythrocytes.
METHODS
Colorado tick fever virus strains. The FLORIO strain was used to prepare serum for virus identification by neutralization tests or fluorescent antibody staining. The 5th passage non-neuroadapted M-919 strain, or virus strains isolated from the blood clots of human cases, were used for experimental infections of cell cultures and animal hosts.
Virus titration and antibody determinations. Virus titrations were performed by standard methods, using tenfold dilutions of stock viruses, plasma, or blood cell fractions to inoculate suckling (I-tO 3-day-old) Swiss white mice (Rockefeller Foundation strain). All virus isolates were identified by a standard neutralization test in mice, using antiserum to Colorado tick fever virus prepared in hamsters, and by fluorescent antibody staining, using the same hyperimmune hamster serum labelled with fluorescein isothiocyanate. Fluorescent antibody staining was also used for identification of virus antigen in blood smears from human cases or experimentally infected animals, as described previously (Emmons & Lennette, I966) . Specificity of the fluorescence was confirmed by positive and negative controls in the staining procedure and by inhibition of the staining when conjugate was absorbed with a 2o % suspension of infected mouse brain.
Standard methods for determining complement-fixing antibody, indirect fluorescent antibody and neutralizing antibody titres (mouse test and plaque reduction test) were used as described elsewhere (Emmons & Lennette, I966; Emmons et al. I969) .
Cell culture methods, utilizing the BHK-zl line of hamster kidney cells, for comparative electron microscopic studies of certain aspects of intracellular infection relating to the present experiments, were described by Emmons et al. (1969) and Oshiro & Emmons (I 968) .
Blood specimen preparation. Blood specimens from experimentally infected animals or from human cases of Colorado tick fever were heparinized to prevent clotting of the blood. The virus was previously shown to be unaffected by heparin (Emmons, 1965) . When serum was needed, separate blood samples without anticoagulant were obtained. After centrifuging at 45o g for 5 min, the plasma was separated from cells and the cells were gently washed three times with 5 to Io vol. of normal saline. The plasma was again centrifuged, to assure removal of all cells. The blood fractions were titrated for virus content immediately if possible, or after storage at -7o °C in flame-sealed glass ampoules. Serum or plasma samples from experimental animals or human cases were held at 4 °C until all samples had been collected, then were tested simultaneously for antibody titre.
Electron microscopic studies. Electron microscopic methods used for examination of infected cell cultures have been described previously (Oshiro & Emmons, 1968) ; for examination of human or mouse blood the following procedure was used. Infected cells were concentrated by centrifuging 2 to 3 ml of heparinized blood at 8oo g for 2o min. After removal of the plasma, 1.2 x 75 mm heparinized capillary tubes were filled ~ full with blood from the reticulocyte layer of the previously centrifuged blood, then were flame-sealed at one end and centrifuged at 8oo g for 2o rain. The section of each capillary tube containing the upper I to 2 mm of the erythrocyte fraction plus the lowermost o.5 to I mm of the buffy coat layer was then broken off, and immersed in toto in 2 % glutaraldehyde
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for several hours to allow penetration of the fixative. The packed, hardened column of cells was pushed out of the capillary tube by inserting a smaller capillary tube into the lumen, fixed in glutaraldehyde for an additional hour, and cut into three or four pieces, identified according to position (buffy coat layer, interphase, and uppermost erythrocyte layer). The cell preparations were washed in o.i M-phosphate buffer (pH 7"5) for several hours and were then fixed in 1% osmium tetroxide, rinsed in phosphate buffer, dehydrated in a graded series of ethanol concentrations, and embedded in Epon. Thin sections were cut and stained with uranyl acetate and lead citrate and were examined in a Siemens Elmiskop I electron microscope.
RESULTS

Viraemia and antibody in mice and man
Laboratory mice were infected with the M-919 strain of Colorado tick fever virus. At each test day, heparinized blood samples from three mice were pooled, and virus titres in the plasma and washed blood fractions were determined daily for I I days and then at 2-or 3-day intervals ( Table I) . The virus titre in the plasma was initially slightly greater than that in the cells, but after 4 days was less; virus was not detectable in the plasma after 8 days. Virus was isolated from washed blood cells until day 48. Antibody was detected on day 2i and thereafter, occurring simultaneously with viraemia for a total of 27 days. Antibody titre end points were not determined in this experiment.
One human case of Colorado tick fever was studied weekly for viraemia and antibody response ( Table 2 ). The plasma yielded virus only on day 6 (low titre). In whole blood, titration results were irregular after day 14, presumably due to the presence of antibody in sufficient titre to partially neutralize the virus. Virus was consistently isolated from washed blood cells at each bleeding. Tests after day 76 were not possible, since the patient withdrew from the study, but viraemia presumably persisted longer. Although the patient suffered a characteristic dengue-like, acute febrile illness, he was free of symptoms after the first 2 weeks and there was nothing unusual about the clinical course.
We have not had the opportunity to study other cases in such detail, but we attempted to determine the approximate duration of cell-associated viraemia by obtaining lateconvalescent, heparinized blood samples from additional cases and processing them as described above, to obtain washed blood cell fractions. Virus isolation was easily accomplished for several weeks after onset in such cases. The virus was isolated from blood and virus antigen was demonstrated in blood smears from one case iot days after onset of clinical illness. Virus antigen was demonstrated in blood cells by fluorescent antibody staining in other cases at 96, 119, I2O, 123, 13o and 135 days after onset, although virus could not be isolated from the washed blood cells. These cases had completely recovered from clinical signs of illness when the late blood samples were obtained, and all had developed significant levels of complement fixing, indirect fluorescent, and/or neutralizing antibody.
Intra-erythrocytic location of virus
Evidence indicating that the virus is located intracellularly, predominantly in the erythrocytes, is summarized below. As reported previously, the erythrocyte fraction, from which all detectable leucocytes were removed, had a virus titre equal to or greater than that of whole blood or of the leucocyte fraction (Emmons, I967) . Immune serum failed to neutralize the virus in blood unless the erythrocytes were disrupted by freezing and thawing or by lysis in distilled water. Infected blood cells stained by the direct fluorescent antibody method (Fig. I) showed an intracellular location of virus antigen. For comparison of the staining characteristics, infected BHK-z x cells are shown in Fig. 2 . The size and morphology of the fluorescing blood cells were identical with that of erythrocytes. Antigen was usually distributed in a few large clumps and numerous finely particulate foci throughout the cell. Counterstaining of blood smears with Giemsa stain and re-examination under ordinary illumination confirmed that almost all fluorescing cells were erythrocytes. In this procedure it was preferable to use so % methanol made up in a solution of 5 % formalin in normal saline as a fixative for the blood smear instead of acetone, since acetone-fixation disrupted the cell architecture and resulted in unsatisfactory Giemsa staining. The staining was dimmer than after acetone fixation, but the fluorescing cells could still be easily located. In rare instances a mononuclear leucocyte appeared to also contain antigen. The fluorescent cells were most abundant in the reticulocyte layer of centrifuged blood. Infected cells located by fluorescence were also re-examined by phase microscopy, by changing the substage condenser, and were consistently seen to be erythrocytes. In some, small inclusions apparent by phase microscopy coincided with concentrations of fluorescing antigen. Attempts to stain the virus in unfixed erythrocytes in suspension by the fluorescent antibody method, or to infect normal erythrocytes in vitro and then demonstrate antigen by fluorescent antibody staining, were not successful, further indicating that virus antigen was inside the erythrocyte, and not adherent to the cell surface. Disruption of the erythrocyte membrane was necessary before antibody could penetrate and combine with the virus antigen.
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Electron microscopic observation of blood cells from a human case (Figs. 3, 4) and from experimentally infected mice (Figs. 5 to 7) revealed particles typical of Colorado tick fever virus within erythrocytes and reticulocytes. Because of the rarity of infected cells, they were only located after long search, and then most easily found in the reticulocyte layer. The virus Fig. 3 . Two Colorado tick fever virus particles within a human erythrocyte. Fig. 4 . Higher magnification of a Colorado tick fever virus particle within a human erythrocyte, Fig. 5 . Colorado tick fever virus particles within a mouse erythrocyte, Fig. 6 . Fibres within a mouse erythrocyte are similar to the intracytoplasmic and intranuclear fibres seen in tissue culture ceils infected with Colorado tick fever virus. A virus particle is also shown within the same cell. particles measured approximately 63 nm in outer diameter with a 50 nm core and were identical in appearance to those seen in infected BHK-2I cells (Fig. 8) . In addition, the unique bundles of fibres described in infected cell cultures by Oshiro & Emmons (I968) and by Murphy et al. 0968) and shown here for comparison (Figs 8, 9) were noted also in mouse erythrocytes (Figs 6, 7 )-These aggregates of virus-associated, electron-dense material could be specifically tagged with ferritin-labelled Colorado tick fever virus antibody, as shown in infected tissue culture cells ( Figs IO, I I) , clearly indicating their antigenic relationship to the virus. Because of the difficulty in locating infected blood cells by electron microscopy, demonstration of ferritin tagging in them has not yet been accomplished. The presence of these fibrillar aggregates, and fluorescing antigen, in the erythrocytes is evidence that virus multiplication has occurred in the cells and that presence of virus particles was not merely due to pinocytosis or to close adherence of virus particles to the cell surface.
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DISCUSSION
The intra-erythrocytic location of Colorado tick fever virus has been shown by electron microscopy, fluorescent antibody staining, phase microscopy, histochemical staining, and virus titration methods. We presume that other blood cells (leucocytes and platelets) are also infected initially, but being short-lived and few in relation to the erythrocytes, they are not readily detected and do not persist in the convalescent phase of the disease. The possibility that virus could also be associated with dislodged capillary endothelial cells, macrophages, or other aberrant cells in the blood stream should also be considered. A transient, moderate anaemia occurs in the disease but usually has not been looked for. Haemolysis has not been recognized as a part of the haematological picture.
The prolonged duration of viraemia is apparently due to the presence of the virus intracellularly in the erythrocytes, protected from antibody or other host defence mechanisms. Erythrocyte precursor cells in the bone marrow are presumably infected at early stages in their development, but at least some of these infected cells continue to mature and are subsequently released into the blood stream. The circulating cells are not all destroyed by the virus or removed in the spleen, and some persist for prolonged periods, perhaps for nearly their normal life-span. The virus either replicates slowly or is stabilized in some way within the erythrocyte. Some metabolic functions persist in erythrocytes well into maturity, perhaps sufficient to support virus replication to some extent. The virus is relatively stable. We have re-isolated it from the blood clot of a human case after I6 months of storage at 4 °C. The prolonged persistence of viraemia has recently been confirmed by others (Earnest et al. I97I ; G. Hughes, unpublished) . There is no evidence thus far that chronic infection of the bone marrow is a source of the persistent viraemia. Our experience with virus isolation and fluorescent antibody staining studies on mice and three human cases, and reports by others (Eklund & Kennedy, I96I ; Gerloff & Larson, 1959) indicate that virus infection of the marrow occurs in the initial stage of infection, but does not persist. This point requires further study however.
Many other studies, too numerous to review here, of experimental or natural virus and rickettsial infections have shown blood cell association, usually with the leucocytes or platelets (see reviews by Mims, I964; Gresser & Lang, I966) . It is of special interest that several of the viruses now assigned to the diplornavirus group, to which Colorado tick fever belongs (Verwoerd, ~97o) , share with this virus the properties of cell-associated viraemia and formation of unusual crystalline or fibrous aggregations of virus-related material in infected cells.
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Examples of virus-erythrocyte association are fewer. Adsorption of virus to erythrocyte stroma, or some other undefined relationship to erythrocytes, has been shown or suggested for lymphocytic choriomeningitis (Traub, 1938; Schwartzman, I944; Mims, T964) , Rift Valley fever (Mims, 1956) ; African swine fever (Sirbu, Ieremia & Bona, 1964) , influenza (Hamre, Appel & Loosli, I956) , hog cholera (Powick, 1937) , equine infectious anaemia (Hyslop, I966) , foot-and-mouth disease, fowl plague, Newcastle disease and mumps (Epstein, Fonseca & DeRoberts, I95I ; Overman, I958) , parvovirus infections (Margolis & Kilham, I97O) , bluetongue and epizootic haemorrhagic disease of deer viruses (G. L. Hoff, personal communication), and hamster osteolytic virus (Portella, I964). Evidence of the intra-erythrocytic location of virus has recently been reported for mammary tumour virus (Nandi & Haslam, I97I) , Rana pipiens virus (Bernard, Cooper & Mandell, 1968) , gecko virus (Stehbens & Johnston, 1966) , Friend leukaemia and Rauscher viruses (Reilly & Schloss, 1971) , certain feline neoplasms (Gardner, 1971) , and C-type viruses in certain disorders of cats (Oshiro et al. 1972) .
A number of implications and suggestions for future studies result from our findings on Colorado tick fever. One practical result is that the presence of virus and virus antigen in erythrocytes for prolonged periods after onset of the disease facilitate diagnosis by virus isolation or fluorescent antibody staining at any stage of illness or convalescence. Although no such instances are known to have occurred, the possibility of man-to-man transmission of the virus via blood transfusion should be recognized. In the natural rodent hosts (chipmunks, field mice, ground squirrels) the prolonged viraemia probably facilitates host-tohost transmission of the virus by vector ticks and contributes to a more stable ecological adaptation of the virus.
Colorado tick fever virus may serve as a useful and convenient model virus for exploring further the mechanism of erythrocyte infection, with implications particularly for other arboviruses, viruses believed to be involved in haemolytic or other haematopathologic states, and various leukaemia viruses. The safety of Colorado tick fever virus for man should not be assumed, however. Although generally producing only a benign, dengue-like illness, it can cause severe disease, with haemorrhagic or meningo-encephalitic complications, and convalescence is often prolonged even in the uncomplicated disease. The possibility is intriguing that a virus which can replicate in bone marrow and blood cells might even be an underlying or inciting cause of leukaemic or other haematological changes.
